SP raises revenue estimate potential for diabetes drug makers
looking at revenue going from 35b to 58 billion in the next few years as unfortunately diabetes diagnosis skyrocket......go Glumetza and SNTS.....the BULL is back....look for Rhuconist update in late Oct. and then earnings report with increased revenue numbers for next year followed by UCERIS labeling info in Dec.
Yes, SanTaurus has a lot of positives coming before year end. This Baby BULL has gouged the heck out of naysayers, traders, and shorts all the way up. For you cowboys, ride this BULL into the sunset!!!!!!!!!!!